Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phenytoin for Megestrol-Induced Memory Impairment
NCT02595723Phase 4Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Jul 2015
- Primary completion
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of phenytoin in cognitive impairment, sponsored by UT Southwestern Medical Center. Started Jul 2015; status: completed.
02
Drugs
phenytoin
03
Conditions
cognitive impairment
Beyond the preview
Go deeper on NCT02595723.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02595723.